102 related articles for article (PubMed ID: 11200053)
1. Pivotal role of 5-lipoxygenase in the activation of human eosinophils: platelet-activating factor and interleukin-5 induce CD69 on eosinophils through the 5-lipoxygenase pathway.
Urasaki T; Takasaki J; Nagasawa T; Ninomiya H
J Leukoc Biol; 2001 Jan; 69(1):105-12. PubMed ID: 11200053
[TBL] [Abstract][Full Text] [Related]
2. Pathways for eosinophil lipid body induction: differing signal transduction in cells from normal and hypereosinophilic subjects.
Bozza PT; Yu W; Cassara J; Weller PF
J Leukoc Biol; 1998 Oct; 64(4):563-9. PubMed ID: 9766638
[TBL] [Abstract][Full Text] [Related]
3. CD69 is expressed by human eosinophils activated in vivo in asthma and in vitro by cytokines.
Hartnell A; Robinson DS; Kay AB; Wardlaw AJ
Immunology; 1993 Oct; 80(2):281-6. PubMed ID: 8262555
[TBL] [Abstract][Full Text] [Related]
4. [Expression of activation antigen CD69 on eosinophils].
Morii T; Nishikawa K; Ako H; Narita N
Nihon Rinsho; 1993 Mar; 51(3):588-92. PubMed ID: 8492431
[TBL] [Abstract][Full Text] [Related]
5. Regulation by IL-5 of expression of functional platelet-activating factor receptors on human eosinophils.
Kishimoto S; Shimadzu W; Izumi T; Shimizu T; Fukuda T; Makino S; Sugiura T; Waku K
J Immunol; 1996 Nov; 157(9):4126-32. PubMed ID: 8892648
[TBL] [Abstract][Full Text] [Related]
6. Activation of human eosinophils by IL-13. Induction of CD69 surface antigen, its relationship to messenger RNA expression, and promotion of cellular viability.
Luttmann W; Knoechel B; Foerster M; Matthys H; Virchow JC; Kroegel C
J Immunol; 1996 Aug; 157(4):1678-83. PubMed ID: 8759755
[TBL] [Abstract][Full Text] [Related]
7. Different densities of human eosinophils respond differently to PAF and IL-5.
Tsai JJ; Wang TF
J Microbiol Immunol Infect; 1999 Mar; 32(1):21-5. PubMed ID: 11561566
[TBL] [Abstract][Full Text] [Related]
8. IL-5 increases expression of 5-lipoxygenase-activating protein and translocates 5-lipoxygenase to the nucleus in human blood eosinophils.
Cowburn AS; Holgate ST; Sampson AP
J Immunol; 1999 Jul; 163(1):456-65. PubMed ID: 10384149
[TBL] [Abstract][Full Text] [Related]
9. Possible induction of intercellular adhesion molecule-1 (ICAM-1) expression on endothelial cells by platelet-activating factor (PAF).
Chihara J; Maruyama I; Yasuba H; Yasukawa A; Yamamoto T; Kurachi D; Mouri T; Seguchi M; Nakajima S
J Lipid Mediat; 1992; 5(2):159-62. PubMed ID: 1356028
[TBL] [Abstract][Full Text] [Related]
10. [The role of 5-lipoxygenase products in the development of airway responsiveness induced by platelet activating factor inhalation in dogs].
Imai T; Adachi M; Idaira K; Takahashi T; Saito C; Maeda M; Tsuji A
Arerugi; 1991 Apr; 40(4):454-63. PubMed ID: 1854258
[TBL] [Abstract][Full Text] [Related]
11. IL-4 determines eicosanoid formation in dendritic cells by down-regulation of 5-lipoxygenase and up-regulation of 15-lipoxygenase 1 expression.
Spanbroek R; Hildner M; Köhler A; Müller A; Zintl F; Kühn H; Rådmark O; Samuelsson B; Habenicht AJ
Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5152-7. PubMed ID: 11320251
[TBL] [Abstract][Full Text] [Related]
12. Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclo-oxygenase metabolites in human blood eosinophils from asthmatics.
Kroegel C; Matthys H
Immunology; 1993 Feb; 78(2):279-85. PubMed ID: 8473016
[TBL] [Abstract][Full Text] [Related]
13. PAF-induced eosinophilic and basophilic differentiation in human hematopoietic precursor cells.
Saito H; Hayakawa T; Mita H; Akiyama K; Shida T
J Lipid Mediat; 1992; 5(2):135-7. PubMed ID: 1525354
[TBL] [Abstract][Full Text] [Related]
14. CD69 and regulation of the immune function.
Marzio R; Mauël J; Betz-Corradin S
Immunopharmacol Immunotoxicol; 1999 Aug; 21(3):565-82. PubMed ID: 10466080
[TBL] [Abstract][Full Text] [Related]
15. Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG.
Bartemes KR; McKinney S; Gleich GJ; Kita H
J Immunol; 1999 Mar; 162(5):2982-9. PubMed ID: 10072549
[TBL] [Abstract][Full Text] [Related]
16. Cytosolic phospholipase A2, increased and activated in the eosinophils of patients with hypereosinophilic syndrome in vivo, is involved in the augmented release of leukotriene C4.
Urasaki T; Ninomiya H; Takasaki J; Kawauchi Y; Nagasawa T; Masuho Y
Inflamm Res; 1999 Jan; 48(1):36-40. PubMed ID: 9987681
[TBL] [Abstract][Full Text] [Related]
17. [Selective differentiation and proliferation of human eosinophils from umbilical cord blood: calcium fluxes and superoxide ion secretion].
Zardini DM; Tschirhart EJ
Therapie; 1999; 54(1):103-9. PubMed ID: 10216433
[TBL] [Abstract][Full Text] [Related]
18. Cytosolic phospholipase A2 activation is essential for beta 1 and beta 2 integrin-dependent adhesion of human eosinophils.
Zhu X; Muñoz NM; Kim KP; Sano H; Cho W; Leff AR
J Immunol; 1999 Sep; 163(6):3423-9. PubMed ID: 10477614
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of type II phospholipase A2 and platelet-activating factor on Mac-1 surface expression and exocytosis of gelatinase granules in human neutrophils: evidence for the 5-lipoxygenase-dependent mechanism.
Takasaki J; Kawauchi Y; Masuho Y
J Immunol; 1998 May; 160(10):5066-72. PubMed ID: 9590257
[TBL] [Abstract][Full Text] [Related]
20. Induction of ICAM-1 expression on the eosinophilic leukemia cell line-3 (EoL-3) by platelet-activating factor and platelet factor 4.
Seguchi M; Nakajima S
Ann Allergy Asthma Immunol; 1995 Mar; 74(3):255-7. PubMed ID: 7889382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
